See All Slides - tctmd.com

Slides

Presentation

Perspectives in Individualized Antiplatelet Therapy: Comorbidities and Characteristics

Presenter: Deepak Bhatt

October 29, 2013

Presentation TCT 2013

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Presenter: Gerhard Schymik

October 29, 2013

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Presenter: Koen Keirse

October 29, 2013

Presentation TCT 2013

Appropriateness Use Criteria Recommendations for Multivessel and Left Main Disease

Presenter: Gregory Dehmer

October 29, 2013

Presentation

Efficient Evaluation for TAVR: What Do We Really Need?

Presenter: John Webb

October 29, 2013

Presentation TCT 2013

PCI and CABG: Do We Really Need Another Trial?

Presenter: A. Pieter Kappetein

October 29, 2013

Presentation TCT 2013

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Presenter: C. Michael Gibson

October 29, 2013

Presentation TCT 2013

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Presenter: Lian R. Gao

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: A HCM Patient Going for Septal Ablation: Step by Step and Potential Pitfalls

Presenter: Ulrich Sigwart

October 29, 2013

Advertisement

Slides

Perspectives in Individualized Antiplatelet Therapy: Comorbidities and Characteristics

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Appropriateness Use Criteria Recommendations for Multivessel and Left Main Disease

Efficient Evaluation for TAVR: What Do We Really Need?

PCI and CABG: Do We Really Need Another Trial?

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Case Presentation and Topic Review: A HCM Patient Going for Septal Ablation: Step by Step and Potential Pitfalls

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content